Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Osteoporos Int ; 27(2): 833-6, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26556740

ABSTRACT

We report the case of a 53-year-old female, treated by bisphosphonate for 12 years, who presented atraumatic fractures of both fibulas. Her X-rays showed bilateral distal fibula fractures with radiological features similar to atypical femur fractures. The distal fibula should be considered as a potential site for stress fractures in bisphosphonate users. Bisphosphonates are the most widely used drugs in the treatment of osteoporosis. During the last decade, the occurrence of atypical fractures, mostly subtrochanteric and diaphyseal femoral fractures, has been acknowledged in patients with long-term use of bisphosphonates. We report the case of a 53-year-old female on alendronate therapy for the past 12 years who presented with a few months history of atraumatic right, and subsequently left, lateral ankle pain. Her X-rays showed bilateral distal fibula fractures with radiological features similar to atypical femur fractures. She had been treated conservatively with walking boots and her treatment with bisphosphonate had been stopped 5 months prior to the fractures. Callus was progressively seen on serial follow-up X-rays, and both fractures healed completely within a reasonable period of 1 year. Investigations did not reveal any secondary causes of osteoporosis or metabolic bone disorders. To our knowledge, this is the first reported case of bilateral distal fibula fractures in a patient on long-term bisphosphonate therapy.


Subject(s)
Bone Density Conservation Agents/adverse effects , Diphosphonates/adverse effects , Fibula/injuries , Fractures, Stress/chemically induced , Alendronate/adverse effects , Alendronate/therapeutic use , Ankle Injuries/chemically induced , Ankle Injuries/diagnostic imaging , Bone Density Conservation Agents/therapeutic use , Diphosphonates/therapeutic use , Female , Fibula/diagnostic imaging , Fractures, Stress/diagnostic imaging , Humans , Middle Aged , Osteoporosis, Postmenopausal/drug therapy , Radiography
3.
Vascul Pharmacol ; 48(1): 14-20, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18065272

ABSTRACT

In the present study, we have investigated the efficacy of Indian ayurvedic herbal formulation Triphala on monosodium urate crystal-induced inflammation in mice; an experimental model for gouty arthritis and compared it with that of the non-steroidal anti-inflammatory drug, Indomethacin. The anti-arthritic effect of Triphala was evaluated by measuring changes in the paw volume, lysosomal enzyme activities, lipid peroxidation, anti-oxidant status and inflammatory mediator TNF-alpha in control and monosodium urate crystal-induced mice. The levels of beta-glucuronidase and lactate dehydrogenase were also measured in monosodium urate crystal-incubated polymorphonuclear leucocytes (PMNL). Triphala treatment (1 gm/kg/b.w. orally) significantly inhibited the paw volume and the levels of lysosomal enzymes, lipid peroxidation and inflammatory mediator tumour necrosis factor-alpha; however the anti-oxidant status was found to be increased in plasma, liver and spleen of monosodium urate crystal-induced mice when compared to control mice. In addition, beta-glucuronidase and lactate dehydrogenase level were reduced in Triphala (100 microg/ml) treated monosodium urate crystal-incubated polymorphonuclear leucocytes. In conclusion, the results obtained clearly indicated that Triphala exerted a strong anti-inflammatory effect against gouty arthritis.


Subject(s)
Arthritis, Experimental/drug therapy , Arthritis, Gouty/drug therapy , Plant Extracts/pharmacology , Acetylglucosaminidase/blood , Acetylglucosaminidase/metabolism , Acid Phosphatase/blood , Acid Phosphatase/metabolism , Administration, Oral , Animals , Ankle Injuries/chemically induced , Ankle Injuries/drug therapy , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/standards , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antioxidants/metabolism , Arthritis, Experimental/blood , Arthritis, Experimental/chemically induced , Arthritis, Gouty/blood , Arthritis, Gouty/chemically induced , Dose-Response Relationship, Drug , Glucuronidase/blood , Glucuronidase/metabolism , Indomethacin/administration & dosage , Indomethacin/pharmacology , Indomethacin/therapeutic use , Injections, Intradermal , L-Lactate Dehydrogenase/metabolism , Lipid Peroxides/blood , Lipid Peroxides/metabolism , Liver/drug effects , Liver/enzymology , Lysosomes/drug effects , Lysosomes/enzymology , Mice , Neutrophils/drug effects , Neutrophils/enzymology , Neutrophils/metabolism , Plant Extracts/administration & dosage , Plant Extracts/therapeutic use , Powders , Spleen/drug effects , Spleen/enzymology , Tumor Necrosis Factor-alpha/metabolism , Uric Acid/administration & dosage , Uric Acid/toxicity , beta-Galactosidase/blood , beta-Galactosidase/metabolism
4.
Unfallchirurg ; 104(5): 448-51, 2001 May.
Article in German | MEDLINE | ID: mdl-11413962

ABSTRACT

We report about a rare case of a pathological fracture of the shank following earlier pathological fractures at other locations in a comparatively young female patient with no history of trauma. There were no known diseases other than psoriasis. The shank fracture was treated surgically by osteosynthesis. Osteoporosis, myeloma, or malignancy as causative factors of this fracture could be excluded. Scintigraphy showed an enhancement, especially at the extremities. Other than reactive bone growth, histological examination revealed no further aspects. Laboratory analysis indicated a massive lack of vitamin D3. After transferring the patient to the internal department of our hospital, long-term medication with fumaric acid was determined to be the reason for the osteomalacia of a Fanconi's syndrome. Three months after cessation of these medicaments and treatment with active vitamin D3 metabolites, the patient was free of complaints. The radiographs showed an essential improvement of the demineralization.


Subject(s)
Ankle Injuries/chemically induced , Fanconi Syndrome/chemically induced , Femoral Neck Fractures/chemically induced , Fractures, Spontaneous/chemically induced , Fumarates/adverse effects , Psoriasis/drug therapy , Tibial Fractures/chemically induced , Adult , Ankle Injuries/diagnostic imaging , Ankle Injuries/surgery , Diagnosis, Differential , Fanconi Syndrome/diagnostic imaging , Fanconi Syndrome/surgery , Female , Femoral Neck Fractures/diagnostic imaging , Femoral Neck Fractures/surgery , Fracture Fixation, Internal , Fractures, Spontaneous/diagnostic imaging , Fractures, Spontaneous/surgery , Humans , Radiography , Reoperation , Tibial Fractures/diagnostic imaging , Tibial Fractures/surgery
5.
J Foot Ankle Surg ; 38(5): 366-9, 1999.
Article in English | MEDLINE | ID: mdl-10553552

ABSTRACT

Chemical burns to the lower extremity can be disabling and of serious consequence if not managed properly. The severity and rapid onset of the burns caused by hydrofluoric acid after initial contact make this a highly dangerous substance. The potential severity of injury and the following complications make it a chemical of which all physicians should have a basic understanding.


Subject(s)
Ankle Injuries/chemically induced , Ankle Injuries/therapy , Burns, Chemical/therapy , Hydrofluoric Acid , Accidents, Occupational , Adult , Anti-Infective Agents, Local/therapeutic use , Debridement , Humans , Male , Silver Sulfadiazine/therapeutic use
6.
Ann Epidemiol ; 6(3): 209-16, 1996 May.
Article in English | MEDLINE | ID: mdl-8827156

ABSTRACT

The purpose of this study was to examine whether geographic area or water fluoride were related to the occurrence of fractures among the elderly in the United States. We used a 5% sample of the white U.S. Medicare population, aged 65 to 89 years during the period 1986-1990, to identify fractures of the hip, proximal humerus, distal forearm, and ankle. The association of geographic region and fluoridation status with fracture rates was assessed using Poisson regression. We found that rates of hip fracture were generally lower in the northern regions of the United States and higher in the southern regions. For fractures of the distal forearm and proximal humerus, lower rates were found in the Western states, and higher rates in the East. No discernible geographic pattern was found for ankle fractures. Adjustment for water fluoridation did not influence these results. Independent of geographic effects, men in fluoridated areas had modestly higher rates of fractures of the distal forearm and proximal humerus than did men in nonfluoridated areas; no such differences were observed among women, nor for fractures of the hip or ankle among either men or women. In conclusion, our data suggest that fractures of the distal forearm and proximal humerus have etiologic determinants distinct from those of fractures of the hip or ankle.


Subject(s)
Fluoridation/adverse effects , Fractures, Bone/epidemiology , Aged , Aged, 80 and over , Ankle Injuries/chemically induced , Ankle Injuries/epidemiology , Cohort Studies , Female , Forearm Injuries/chemically induced , Forearm Injuries/epidemiology , Fractures, Bone/chemically induced , Hip Fractures/chemically induced , Hip Fractures/epidemiology , Humans , Incidence , Male , Medicare/statistics & numerical data , Sampling Studies , Sex Distribution , Shoulder Fractures/chemically induced , Shoulder Fractures/epidemiology , United States/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...